Soy protein, isoflavones and cardiovascular disease risk

Journal of Nutrition

Volumn 128, Issue 10, 1998, Pages 1589-1592

  Lichtenstein, Alice H ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Cholesterol; Coronary heart disease; Daidzein; Genistein; Glycetein; Isoflavones; LDL; Phytoestrogens; Soy protein; Soybean

Indexed keywords

CHOLESTEROL; DAIDZEIN; GENISTEIN; ISOFLAVONE; LOW DENSITY LIPOPROTEIN; SOYBEAN PROTEIN;

ARTERY COMPLIANCE; BILE ACID METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; ESTROGEN ACTIVITY; HUMAN; PROTEIN STRUCTURE; REVIEW; SOYBEAN; THYROID FUNCTION;

EID: 0031665212     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/128.10.1589     Document Type: Review

References (56)

1. Adlercreutz, H. (1990) Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Investig. (suppl.) 201: 3-23.
2. Anderson, J. W., Johnstone, B. M. & Cook-Newell, M. E. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333: 276-282.
3. Anderson, R. L. & Wolf, W. J. (1995) Compositional changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J. Nutr. 125: 581S-588S.
4. Anthony, M. S., Clarkson, T. B., Hughes, C. L., Morgan, T. M. & Burke, G. L. (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr. 126: 43-50.
5. Anthony, M. S., Clarkson, T. B., Bullock, B. C. & Wagner, J. D. (1997) Soy protein versus soy phytoestrogens in prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arteriosler. Thromb. Vasc. Biol. 17: 2524-2531.
6. Bakhit, R. M., Klein, B. P., Essex-Sorlie, D., Ham, J. O., Erdman, J. W. & Potter, S. M. (1994) Intake of 25 g of soybean protein with or without soybean fiber alters plasma lipids in men with elevated cholesterol concentrations. J. Nutr. 124: 213-222.
7. Balmir, F, Staack, R., Jeffery, E., Jimerez, M.D.B., Wand, L. & Potter, S. M. (1996) An extract of soy flour influences serum cholesterol and thyroid hormones in rats and hamsters. J. Nutr. 126: 3046-3053.
8. Campbell, K. L., Czarnecki-Maulden, G. L. & Schaeffer, J. D. (1995) Effects of animal and soy fats and proteins in the diet on fatty acid concentrations in the serum and skin of dogs. Am. J. Vet. Res. 56: 1465-1469.
9. Carroll, K. K. & Kurowska, E. M. (1995) Soy consumption and cholesterol reduction: review of animal and human studies. J. Nutr. 125: 594S-597S.
10. Cassidy, A., Bingham, S. & Setchell, K. (1995) Biological effects of isoflavonoids in young women: importance of the chemical composition of soyabean products. Br. J. Nutr. 74: 587-601.
11. Clarkson, T. B., Anthony, M. S., Williams, J. K., Honore, E. K. & Cline, J. M. (1998) The potential of soybean phytoestrogens for postmenopausal hormone replacement therapy. Proc. Soc. Exp. Biol. Med. 217: 365-368.
12. Connor, W. & Connor, S. (1997) Should low fat, high carbohydrate diet be recommended for everyone? (Editorial). N. Engl. J. Med. 337: 562-563.
13. Davis, S. R., Murkies, A. L. & Wilcox, G. (1998) Phytoestrogens in clinical practice, Integr. Med. 1: 27-34.
14. de Whalley, C. V., Rankin, S. M., Hoult, J.R.S., Jessup, W. & Leake, D. S. (1990) Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharm. 39: 1743-1750.
15. Dwyer, J. T., Goldin, B. R., Saul, N., Gualtieri, L., Barakat, S. & Adlercreutz, H. (1994) Tofu and soy drinks contain phytoestrogens. J. Am. Diet. Assoc. 94: 739-743.
16. Eaker, E. D., Chesebro, J. H., Sacks, F. M., Wenger, N. K., Whisnant, J. P. & Winston, M. (1993) Cardiovascular disease in women. Circulation 88: 1999-2009.
17. Forsythe, W. A., III (1995) Soy protein, thyroid regulation and cholesterol metabolism. J. Nutr. 125: 619S-623S.
18. Fumagalli, R., Soleri, L., Farina, R., Musanti, R., Mantero, O., Noseda, G., Gatti, E. & Sirtori, C. R. (1982) Fecal cholesterol excretion studies in type II hypercholesterolemic patients treated with the soybean protein diet. Atherosclerosis 43: 341-353.
19. Gooderham, M. J., Adlercreut, H., Ojala, S. T., Wahala, K. & Holub, B. J. (1996) A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J. Nutr. 126: 2000-2006.
20. Grundy, S. M. & Abrams, J. J. (1983) Comparison of actions of soy protein and casein on metabolism of plasma lipoproteins and cholesterol in humans. Am. J. Clin. Nutr. 38: 245-252.
21. Hodges, R. E., Krehl, W. A., Stone, D. B. & Lopez, A. (1967) Dietary carbohydrates and low cholesterol diets: effects on serum lipids of man. Am. J. Clin. Nutr. 20: 198-208.
22. Holmes, W. L., Rubel, G. B. & Hood, S. S. (1980) Comparison of the effect of dietary meat with dietary soybean protein on plasma lipids of hyperlipidemic individuals. Atherosclerosis 36: 379-387.
23. Honore, E. K., Williams, J. K., Anthony, M. S. & Clarkson, T. B. (1997) Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil. Steril. 67: 148-154.
24. Huff, M. W., Hamilton, R.M.G. & Carroll, K. K. (1977) Plasma cholesterol levels in rabbits fed low fat, cholesterol-free, semipurified diets: effects of dietary proteins, protein hydrolysates and amino acid mixtures. Atherosclerosis 28: 187-195.
25. Hutchins, A. M., Slavin, J. L. & Lampe, J. W. (1995) Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products. J. Am. Diet. Assoc. 95: 545-551.
26. Jacques, H., Laurin, D., Moorjani, S., Steinke, F. H., Gagne, C., Brun, D. & Lupien, P.-J. (1992) Influence of diets containing cow's milk or soy protein beverage on plasma lipids in children with familial hypercholesterolemia. J. Am. Coll. Nutr. 11: 69S-73S.
27. Kanazawa, T., Osanai, T., Zhang, X. S., Uemura, T., Yin, X. Z., Onodera, K., Dike, Y. & Ohkubo, K. (1995) Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular disease. J. Nutr. 125: 639S-646S.
28. Kapiotis, S., Hermann, M., Held, I., Seelos, C., Ehringer, H. & Gmeiner, B.M.K. (1997) Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler. Thromb. Vasc. Biol. 17: 2868-2874.
29. Karr, S. C., Lampe, J., Hutchins, A. M. & Slavin, J. L. (1997) Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am. J. Clin. Nutr. 66: 46-51.
30. Katan, M. B., Grundy, S. M. & Willett, W. C. (1997) Beyond low-fat diets. N. Engl. J. Med. 337: 563-566.
31. Kelly, G. E., Joannou, G. E., Reeder, A. Y., Nelson, C. & Waring, M. A. (1995) The variable metabolic response to dietary isoflavones in humans. Proc. Soc. Exp. Biol. Med. 208: 40-43.
32. Kritchevsky, D. (1995) Dietary protein, cholesterol and atherosclerosis: a review of the early history. J. Nutr. 125: 589S-593S.
33. Lampe, J. W., Karr, S. C., Hutchins, A. M. & Slavin, J. L. (1998) Urinary equol excretion with a soy challenge: influence of habitual diet. Proc. Soc. Exp. Biol. Med. 217: 335-339.
34. Lusas, E. W. & Riaz, M. B. (1995) Soy protein: processing and use. J. Nutr. 125: 573S-580S.
35. Miksicek, R. J. (1995) Estrogenic flavonoids: structural requirements for biological activity. Proc. Soc. Exp. Biol. Med. 208: 44-50.
36. Morton, M. S., Wilcox, G., Wahlquist, M. L. & Griffiths, K. (1994) Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J. Endocrinol. 142: 251-259.
37. Nagaoka, S., Awano, R., Nagata, N., Masaoka, M., Hori, G. & Hashimoto, K. (1997) Serum cholesterol reduction and cholesterol absorption inhibition in Caco-2 cells by a soyprotein peptic hydrolyzate. Biosci. Biotechnol. Biochem. 61: 354-356.
38. Nestel, P. J., Yamashita, T., Sasahara, T., Pomeroy, S., Dart, A., Lomesaroff, P., Owen, A. & Abbey, M. (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler. Thromb. Vasc. Biol. 17: 3392-3398.
39. Pelletier, X., Belbraouet, S., Mirabel, D., Mordret, F., Perrin, J. L., Pages, X. & Debry, G. (1995) A diet moderately enriched in phytosterols lowers plasma cholesterol concentrations in normocholesterolemic humans. Ann. Nutr. Metab. 39: 291-295.
40. Potter, S. M. (1996) Soy protein and serum lipids. Curr. Opin. Lipidol. 7: 260-264.
41. Potter, S. M., Bakhit, R. M., Essex-Sorlie, D. L., Weingartner, K. E., Chapman, K. M., Nelson, R. A., Prabhudesai, M., Savage, W. D., Nelson, A. I., Winter, L. W. & Erdman, J. W. (1993) Depression of plasma cholesterol in men by consumption of baked products containing soy protein. Am. J. Clin. Nutr 58: 501-506.
42. Potter, S. M., Pertile, J. & Berber-Jimenez, M. D. (1996) Soy protein concentrate and isolated soy protein similarly lower blood serum cholesterol but differently affects thyroid hormones in hamsters. J. Nutr. 126: 2007-20111.
43. Ruiz-Larrea, M. B., Mohan, A. R., Paganga, G., Miller, N. J., Bolwell, G. P., Pice-Evans, (1997) Antioxidant activity of phytoestrogenic isoflavones. Free Radic. Res. 26: 63-70.
44. Schaefer, E. J. & Levy, R. I. (1985) The pathogenesis and management of lipoprotein disorders. N. Engl. J. Med. 312: 1300-1310.
45. Sekizaki, H., Yokosawa, R., Chinen, C., Adachi, H. & Yamane, Y. (1993) Synthesis is isoflavones and their attracting activity to Aphanomyces euteiches zoospore. Biol. Pharm. Bull. 16: 698-701.
46. Shorey, R. L., Brazan, B., Lo, G. S. & Steinke, F. H. (1981) Determinants of hypercholesterolemic response to soy and animal protein-based diets. Am. J. Clin. Nutr. 34: 1769-1778.
47. Sirtori, C. R., Lovati, M. R., Manzoni, C., Monetti, M., Pazzucconi, F. & Gatti, E. (1995) Soy and cholesterol reduction: clinical experience. J. Nutr. 125: 598S-605S.
48. Steinberg, D. (1997) Oxidative modification of low density lipoprotein and atherosclerosis. Circulation 95: 1062-1071.
49. Tasker, T. E. & Potter, S. M. (1993) Effects of dietary protein source on plasma lipids, HMG CoA reductase activity, and hepatic glutathione levels in gerbils. J. Nutr. Biochem. 4: 458-462.
50. Teixeira, S., Potter, S. M., Weigel, R., Hannum, S., Erdman, J. W. & Hasler, C. M. (1998) Dose-dependent effects of soy protein in hypercholesterolemic men. FASEB J. 12: A237 (abs.).
51. Tew, B.-Y., Xu, X., Wang, H.-J., Murphy, P. A. & Hendrich, S. (1996) A diet high in wheat fiber decreases the bioavailability of soybean isoflavones in a single meal fed to women. J. Nutr. 126: 871-877.
52. Wang, M.-F., Yamamoto, S., Chung, H.-M., Chung, S.-Y., Miyatani, S., Mori, M., Okita, T. & Sugano, M. (1995) Antihypercholesterolemic effect of undigested fraction of soybean protein in young female volunteers. J. Nutr. Sci. Vitaminol. 41: 187-195.
53. Wei, H. C., Wei, L. H., Frenkel, K., Bowen, R. & Barnes, S. (1993) Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr. Cancer 20: 1-12.
54. 18O-cholesterol and hypocholesterolemic effect of soy protein. J. Nutr. 125: 612S-618S.
55. Xu, X., Harris, K. S., Wang, H.-J., Murphy, P. A. & Hendrich, S. (1995) Bioavailability of soybean isoflavones depends upon gut microflora in women. J. Nutr. 125: 2307-2315.
56. Xu, X., Wang, H.-J., Murphy, P. A., Cook, L. & Hendrich, S. (1994) Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124: 825-832.